Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPSZacks Investment Research • 07/30/26
Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trialsReuters • 07/30/26
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 DevelopmentBusiness Wire • 07/24/26
Will Keytruda Remain the Driving Force Behind Merck's Q2 Performance?Zacks Investment Research • 07/22/26
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?Zacks Investment Research • 07/21/26
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral TherapyBusiness Wire • 07/21/26
Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your PortfolioBenzinga • 07/20/26
What Comes After Merck's Keytruda? The Race for the Next Standard Cancer Treatment.Barrons • 07/20/26
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?24/7 Wall Street • 07/17/26
Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies.Investors Business Daily • 07/17/26
FDA signs off on Merck's cholesterol-lowering pill — the first oral treatment of its kindNew York Post • 07/16/26
The FDA approved Lipfendra, a first-of-its kind pill from Merck that is designed to help lower cholesterol levels beyond what statins alone can achieveWSJ • 07/16/26